ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 59 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $79,500 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 485,340 | $771,691 | 0.00% |
| TWO SIGMA ADVISERS, LP | 427,200 | $679,248 | 0.00% |
| MORGAN STANLEY | 6,965,432 | $11,075,037 | 0.00% |
| GOLDMAN SACHS GROUP INC | 4,561,168 | $7,252,257 | 0.00% |
| Tower Research Capital LLC (TRC) | 9,498 | $15,102 | 0.00% |
| NWAM LLC | 10,000 | $15,900 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 84,278 | $134,002 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5,591,790 | $8,890,947 | 0.00% |
| FMR LLC | 7,761,292 | $12,340,454 | 0.00% |
| Bank of New York Mellon Corp | 69,162 | $109,968 | 0.00% |
| Blue Trust, Inc. | 1,500 | $1 | 0.00% |
| JPMORGAN CHASE & CO | 1,827 | $2,905 | 0.00% |
| ROYAL BANK OF CANADA | 2,402 | $4,000 | 0.00% |
| Allworth Financial LP | 20 | $32 | 0.00% |
| VANGUARD GROUP INC | 4,062,034 | $6,458,634 | 0.00% |
| JANE STREET GROUP, LLC | 46,629 | $74,140 | 0.00% |
| Cubist Systematic Strategies, LLC | 30,758 | $48,905 | 0.00% |
| UBS Group AG | 6,290 | $10,001 | 0.00% |
| RHUMBLINE ADVISERS | 2,937 | $4,669 | 0.00% |
External links
This page lists ADVERUM BIOTECHNOLOGIES INC's shareholders in Q2 2023. To view ADVERUM BIOTECHNOLOGIES INC's shareholder history, click here.